 | • レポートコード：GIR-2104Z11798 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、組換えワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。組換えワクチンの種類別市場規模（サブユニット組換えワクチン、弱毒化組換えワクチン、ベクター組換えワクチン）、用途別市場規模（組換えヒトワクチン、動物組換えワクチン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・組換えワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co., Inc、Green Cross Corporation、Pfizer Inc.、Bayer AG、Sanofi S A.、Protein Science Corporation、GlaxoSmithKline Plc.、Novartis AG、Bharat Biotech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：サブユニット組換えワクチン、弱毒化組換えワクチン、ベクター組換えワクチン ・用途別分析2016年-2026年：組換えヒトワクチン、動物組換えワクチン ・組換えワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・組換えワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・組換えワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・組換えワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・組換えワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Market segment by Application can be divided into
Recombinant Human Vaccines
Animal Recombinant Vaccines
The key market players for global Recombinant Vaccines market are listed below:
Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Subunit Recombinant Vaccines
1.2.3 Attenuated Recombinant Vaccines
1.2.4 Vector Recombinant Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Recombinant Human Vaccines
1.3.3 Animal Recombinant Vaccines
1.4 Global Recombinant Vaccines Market Size & Forecast
1.4.1 Global Recombinant Vaccines Sales in Value (2016-2026))
1.4.2 Global Recombinant Vaccines Sales in Volume (2016-2026)
1.4.3 Global Recombinant Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Recombinant Vaccines Production Capacity Analysis
1.5.1 Global Recombinant Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Vaccines Market Drivers
1.6.2 Recombinant Vaccines Market Restraints
1.6.3 Recombinant Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co., Inc
2.1.1 Merck & Co., Inc Details
2.1.2 Merck & Co., Inc Major Business
2.1.3 Merck & Co., Inc Recombinant Vaccines Product and Services
2.1.4 Merck & Co., Inc Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Green Cross Corporation
2.2.1 Green Cross Corporation Details
2.2.2 Green Cross Corporation Major Business
2.2.3 Green Cross Corporation Recombinant Vaccines Product and Services
2.2.4 Green Cross Corporation Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business
2.3.3 Pfizer Inc. Recombinant Vaccines Product and Services
2.3.4 Pfizer Inc. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Recombinant Vaccines Product and Services
2.4.4 Bayer AG Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi S A.
2.5.1 Sanofi S A. Details
2.5.2 Sanofi S A. Major Business
2.5.3 Sanofi S A. Recombinant Vaccines Product and Services
2.5.4 Sanofi S A. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Protein Science Corporation
2.6.1 Protein Science Corporation Details
2.6.2 Protein Science Corporation Major Business
2.6.3 Protein Science Corporation Recombinant Vaccines Product and Services
2.6.4 Protein Science Corporation Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 GlaxoSmithKline Plc.
2.7.1 GlaxoSmithKline Plc. Details
2.7.2 GlaxoSmithKline Plc. Major Business
2.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Product and Services
2.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Recombinant Vaccines Product and Services
2.8.4 Novartis AG Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Bharat Biotech
2.9.1 Bharat Biotech Details
2.9.2 Bharat Biotech Major Business
2.9.3 Bharat Biotech Recombinant Vaccines Product and Services
2.9.4 Bharat Biotech Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Vaccines Sales by Manufacturer
3.1 Global Recombinant Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Vaccines Manufacturer Market Share
3.4.2 Top 6 Recombinant Vaccines Manufacturer Market Share
3.5 Global Recombinant Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Vaccines Market Size by Region
4.1.1 Global Recombinant Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Vaccines Revenue by Region (2016-2026)
4.2 North America Recombinant Vaccines Revenue (2016-2026)
4.3 Europe Recombinant Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Vaccines Revenue (2016-2026)
4.5 South America Recombinant Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Vaccines Revenue by Type (2016-2026)
5.3 Global Recombinant Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Vaccines Revenue by Application (2016-2026)
6.3 Global Recombinant Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Vaccines Sales by Type (2016-2026)
7.2 North America Recombinant Vaccines Sales by Application (2016-2026)
7.3 North America Recombinant Vaccines Market Size by Country
7.3.1 North America Recombinant Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Vaccines Sales by Type (2016-2026)
8.2 Europe Recombinant Vaccines Sales by Application (2016-2026)
8.3 Europe Recombinant Vaccines Market Size by Country
8.3.1 Europe Recombinant Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Vaccines Market Size by Region
9.3.1 Asia-Pacific Recombinant Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Vaccines Sales by Type (2016-2026)
10.2 South America Recombinant Vaccines Sales by Application (2016-2026)
10.3 South America Recombinant Vaccines Market Size by Country
10.3.1 South America Recombinant Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Vaccines Market Size by Country
11.3.1 Middle East & Africa Recombinant Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Vaccines Typical Distributors
12.3 Recombinant Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc Major Business
Table 5. Merck & Co., Inc Recombinant Vaccines Product and Services
Table 6. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Green Cross Corporation Major Business
Table 9. Green Cross Corporation Recombinant Vaccines Product and Services
Table 10. Green Cross Corporation Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Inc. Major Business
Table 13. Pfizer Inc. Recombinant Vaccines Product and Services
Table 14. Pfizer Inc. Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 16. Bayer AG Major Business
Table 17. Bayer AG Recombinant Vaccines Product and Services
Table 18. Bayer AG Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi S A. Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi S A. Major Business
Table 21. Sanofi S A. Recombinant Vaccines Product and Services
Table 22. Sanofi S A. Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Protein Science Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Protein Science Corporation Major Business
Table 25. Protein Science Corporation Recombinant Vaccines Product and Services
Table 26. Protein Science Corporation Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline Plc. Major Business
Table 29. GlaxoSmithKline Plc. Recombinant Vaccines Product and Services
Table 30. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis AG Major Business
Table 33. Novartis AG Recombinant Vaccines Product and Services
Table 34. Novartis AG Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 36. Bharat Biotech Major Business
Table 37. Bharat Biotech Recombinant Vaccines Product and Services
Table 38. Bharat Biotech Recombinant Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Recombinant Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Recombinant Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Recombinant Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Recombinant Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Recombinant Vaccines Production Site of Key Manufacturer
Table 44. Global Recombinant Vaccines Sales by Region (2016-2021e) & (K Units)
Table 45. Global Recombinant Vaccines Sales by Region (2021-2026) & (K Units)
Table 46. Global Recombinant Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Recombinant Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Recombinant Vaccines Sales by Type (2016-2021e) & (K Units)
Table 49. Global Recombinant Vaccines Sales by Type (2021-2026) & (K Units)
Table 50. Global Recombinant Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Recombinant Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Recombinant Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Recombinant Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Recombinant Vaccines Sales by Application (2016-2021e) & (K Units)
Table 55. Global Recombinant Vaccines Sales by Application (2021-2026) & (K Units)
Table 56. Global Recombinant Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Recombinant Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Recombinant Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Recombinant Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Recombinant Vaccines Sales by Country (2016-2021e) & (K Units)
Table 61. North America Recombinant Vaccines Sales by Country (2021-2026) & (K Units)
Table 62. North America Recombinant Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Recombinant Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Recombinant Vaccines Sales by Type (2016-2021e) & (K Units)
Table 65. North America Recombinant Vaccines Sales by Type (2021-2026) & (K Units)
Table 66. North America Recombinant Vaccines Sales by Application (2016-2021e) & (K Units)
Table 67. North America Recombinant Vaccines Sales by Application (2021-2026) & (K Units)
Table 68. Europe Recombinant Vaccines Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Recombinant Vaccines Sales by Country (2021-2026) & (K Units)
Table 70. Europe Recombinant Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Recombinant Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Recombinant Vaccines Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Recombinant Vaccines Sales by Type (2021-2026) & (K Units)
Table 74. Europe Recombinant Vaccines Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Recombinant Vaccines Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Recombinant Vaccines Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Recombinant Vaccines Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Recombinant Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Recombinant Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Recombinant Vaccines Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Recombinant Vaccines Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Recombinant Vaccines Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Recombinant Vaccines Sales by Application (2021-2026) & (K Units)
Table 84. South America Recombinant Vaccines Sales by Country (2016-2021e) & (K Units)
Table 85. South America Recombinant Vaccines Sales by Country (2021-2026) & (K Units)
Table 86. South America Recombinant Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Recombinant Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Recombinant Vaccines Sales by Type (2016-2021e) & (K Units)
Table 89. South America Recombinant Vaccines Sales by Type (2021-2026) & (K Units)
Table 90. South America Recombinant Vaccines Sales by Application (2016-2021e) & (K Units)
Table 91. South America Recombinant Vaccines Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Recombinant Vaccines Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Recombinant Vaccines Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Recombinant Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Recombinant Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Recombinant Vaccines Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Recombinant Vaccines Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Recombinant Vaccines Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Recombinant Vaccines Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Recombinant Vaccines Typical Distributors
Table 103. Recombinant Vaccines Typical Customers
List of Figures
Figure 1. Recombinant Vaccines Picture
Figure 2. Global Recombinant Vaccines Sales Market Share by Type in 2020
Figure 3. Subunit Recombinant Vaccines
Figure 4. Attenuated Recombinant Vaccines
Figure 5. Vector Recombinant Vaccines
Figure 6. Global Recombinant Vaccines Sales Market Share by Application in 2020
Figure 7. Recombinant Human Vaccines
Figure 8. Animal Recombinant Vaccines
Figure 9. Global Recombinant Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Recombinant Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Recombinant Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Recombinant Vaccines Sales (2016-2026) & (K Units)
Figure 31. Global Recombinant Vaccines Production Capacity (2016-2026) & (K Units)
Figure 32. Global Recombinant Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Recombinant Vaccines Market Drivers
Figure 34. Recombinant Vaccines Market Restraints
Figure 35. Recombinant Vaccines Market Trends
Figure 36. Global Recombinant Vaccines Sales Market Share by Manufacturer in 2020
Figure 37. Global Recombinant Vaccines Revenue Market Share by Manufacturer in 2020
Figure 38. Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Recombinant Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Recombinant Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Recombinant Vaccines Sales Market Share by Region (2016-2026)
Figure 42. Global Recombinant Vaccines Revenue Market Share by Region (2016-2026)
Figure 43. North America Recombinant Vaccines Revenue (2016-2026) & (USD Million)
Figure 44. Europe Recombinant Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Recombinant Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. South America Recombinant Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Recombinant Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Global Recombinant Vaccines Sales Market Share by Type (2016-2026)
Figure 49. Global Recombinant Vaccines Revenue Market Share by Type (2016-2026)
Figure 50. Global Recombinant Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Recombinant Vaccines Sales Market Share by Application (2016-2026)
Figure 52. Global Recombinant Vaccines Revenue Market Share by Application (2016-2026)
Figure 53. Global Recombinant Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Recombinant Vaccines Sales Market Share by Country (2016-2026)
Figure 55. North America Recombinant Vaccines Revenue Market Share by Country (2016-2026)
Figure 56. North America Recombinant Vaccines Sales Market Share by Type (2016-2026)
Figure 57. North America Recombinant Vaccines Sales Market Share by Application (2016-2026)
Figure 58. Europe Recombinant Vaccines Sales Market Share by Country (2016-2026)
Figure 59. Europe Recombinant Vaccines Revenue Market Share by Country (2016-2026)
Figure 60. Europe Recombinant Vaccines Sales Market Share by Type (2016-2026)
Figure 61. Europe Recombinant Vaccines Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Recombinant Vaccines Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Recombinant Vaccines Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Recombinant Vaccines Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Recombinant Vaccines Sales Market Share by Application (2016-2026)
Figure 66. South America Recombinant Vaccines Sales Market Share by Country (2016-2026)
Figure 67. South America Recombinant Vaccines Revenue Market Share by Country (2016-2026)
Figure 68. South America Recombinant Vaccines Sales Market Share by Type (2016-2026)
Figure 69. South America Recombinant Vaccines Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Recombinant Vaccines Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Recombinant Vaccines Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Recombinant Vaccines Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Recombinant Vaccines Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のワクチン＆ワクチン接種市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaccines & Vaccination Market The global Vaccines & Vaccination market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…- 世界の組換え抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant Antibody Market The global Recombinant Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年） Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. Market Analysis and Insights: Global Antihemophilic Factor (Recombinant) Market The global Antihemophilic Factor (Recombinant) market size is projected to reach US$ XX million by 2027, from US$ XX million i…
- 世界の獣医用ワクチン市場規模・現状・予測（2021年-2027年） Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock product…
- 世界の組換えタンパク質治療薬市場規模・現状・予測（2021年-2027年） In the 1970s, recombinant DNA technology hardly opened a new era of pharmaceutical biotechnology. Therefore, the definition of protein therapeutics covers drugs that are structurally proteins or peptides, as well as drugs obtained through recombinant DNA technology. Market Analysis and Insights: Glo…